This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Chlorpromazine (CPZ) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for chlorpromazine. It is purified by protein A. It can be applied to ELISA, WB, FIA and CLIA assays of chlorpromazine. The antigen for this antibody is VG8F241.
Specifications
Target Information
Chlorpromazine is a phenothiazine antipsychotic that targets dopamine receptors, particularly the D2 subtype, in the brain. It also interacts with other neurotransmitter systems, including serotonin and norepinephrine receptors. By blocking these receptors, chlorpromazine reduces dopamine activity, which is beneficial in managing symptoms of schizophrenia and other psychotic disorders. Additionally, it has sedative and antiemetic properties. Its specific interactions with dopamine and other receptors make it a relevant target for antibody development to enhance its therapeutic efficacy and specificity in treating psychiatric and neurological conditions.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.